CD147 Mediates 5-Fluorouracil Resistance in Colorectal Cancer by Reprogramming Glycolipid Metabolism.

导出 LinkOut

翻译打印收藏纠错

作者： Shuohui,Dong ^[1] ; Songhan,Li ^[1] ; Xiaoyan,Wang ^[2] ; Shuo,Liang ^[3] ; Wenjie,Zhang ^[1] ; Linchuan,Li ^[4] ; Qian,Xu ^[1] ; Bowen,Shi ^[1] ; Zhiqiang,Cheng ^[5] ; Xiang,Zhang ^[5] ; Mingwei,Zhong ^[4] ; Guangyong,Zhang ^[4] ; Sanyuan,Hu ^[1]

作者单位： Department of General Surgery, Shandong Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. ^[1] Department of Neonatology, Weifang Yidu Central Hospital, Weifang, China. ^[2] Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial Ear-nose-throat (ENT) Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. ^[3] Department of General Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, China. ^[4] Department of General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. ^[5]

关键词 5-fluorouracil CD147 chemoresistance colorectal cancer glycolipid metabolism reprogramming

DOI 10.3389/fonc.2022.813852

PMID 35898887

发布时间 2022-07-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

813852页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

CD147 Mediates 5-Fluorouracil Resistance in Colorectal Cancer by Reprogramming Glycolipid Metabolism.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

CD147 Mediates 5-Fluorouracil Resistance in Colorectal Cancer by Reprogramming Glycolipid Metabolism.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除